vaminolac innrennslislyf, lausn
fresenius kabi ab - histidinum inn; phenylalaninum inn; leucinum inn; tyrosinum inn; serinum inn; lysinum inn; cysteinum inn; glycinum inn; prolinum inn; tryptophanum inn; methioninum inn; threoninum inn; isoleucinum inn; taurinum inn; acidum glutamicum inn; valinum inn; argininum inn; acidum asparticum inn; alaninum inn - innrennslislyf, lausn
vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg
sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg
repevax stungulyf, dreifa áfyllt sprauta
sanofi pasteur* - tetanus toxoid; diphtheria toxoid; pertussis toxoid; filamentous haemagglutinin; pertussis fimbrial agglutinogens (fim) 2 and 3; pertactin; poliovirus (inactivated) type 1 (mahoney strain); poliovirus (inactivated) type 2 (mef-1 strain); poliovirus (inactivated) type 3 (saukett strain) - stungulyf, dreifa - áfyllt sprauta
colobreathe
teva b.v. - colistimethate járn - cystic fibrosis - sýklalyf fyrir almenn nota, - colobreathe er ætlað til meðferðar við langvarandi lungnabólgu vegna pseudomonas aeruginosa hjá sjúklingum með blöðruhálskirtli (cf) á aldrinum sex ára og eldri. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.
amlodipin bluefish tafla 10 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 10 mg
amlodipine vitabalans tafla 10 mg
vitabalans oy - amlodipinum besýlat - tafla - 10 mg
amlodipin bluefish tafla 5 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 5 mg
amlodipine vitabalans tafla 5 mg
vitabalans oy - amlodipinum besýlat - tafla - 5 mg
amlodipin zentiva tafla 10 mg
zentiva k.s.* - amlodipinum besýlat - tafla - 10 mg
amlodipin zentiva tafla 2,5 mg
zentiva k.s. - amlodipinum besýlat - tafla - 2,5 mg